About Amylyx Pharmaceuticals, Inc. 
Amylyx Pharmaceuticals, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 52 Schemes (27.29%)
Foreign Institutions
Held by 100 Foreign Institutions (13.23%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
(Quarterly Results - Jun 2025)
Net Profit:
-41 Million
Pharmaceuticals & Biotechnology
USD 931 Million ()
NA (Loss Making)
NA
0.00%
-1.07
-90.18%
5.55






